Look for:

Our offer for

GILEAD SCIENCES INC.


ISIN:
US3755581036
WKN:
375558103

2024/12/06 22:00:00
Price
92.13 USD
Difference -1.35% (-1.26)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)108,469 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)92.00 USD (100)
Ask (Ask size)92.13 USD (700)
Open93.50 USD
High94.218 USD
Low92.03 USD
Close (prev. day)93.39 USD
VWAP92.443688 USD
Volume (pcs)4,470,730
Trading volume413,439,837.10
Number of trades52,530
Last size-

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: GILEAD SCIENCES INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/12/06 22:00:00
Price
92.13 USD
Difference -1.35% (-1.26)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)108,469 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)92.00 USD (100)
Ask (Ask size)92.13 USD (700)
Open93.50 USD
High94.218 USD
Low92.03 USD
Close (prev. day)93.39 USD
VWAP92.443688 USD
Volume (pcs)4,470,730
Trading volume413,439,837.10
Number of trades52,530
Last size-

Performance and Risk

6m1Y3Y
Perf (%)+48.79%+18.29%+41.66%
Perf (abs.)+28.61+13.49+25.66
Beta0.070.120.43
Volatility26.3325.7023.86
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)92.72 USD (7,315,905)
Ø price 30 days | Ø volume 30 days (pcs.)91.28 USD (7,208,271)
Ø price 100 days | Ø volume 100 days (pcs.)83.37 USD (6,512,823)
Ø price 250 days | Ø volume 250 days (pcs.)76.75 USD (7,044,640)
YTD High | date98.90 USD (2024/11/11)
YTD Low | date62.07 USD (2024/05/31)
52 Weeks High | date98.90 USD (2024/11/11)
52 Weeks Low | date62.07 USD (2024/05/31)

All listings for GILEAD SCIENCES INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/12/0617:3587.61 EUR0.1226
Vienna Stock Exchange2024/12/0617:3287.67 EUR0.005
Tradegate2024/12/0622:2687.18 EUR0.1738
Stuttgart2024/12/0620:2487.51 EUR0.005
SIX Swiss Exchange2022/11/0217:3679.50 CHF0.001
SIX Swiss Exchange2020/04/1717:3585.00 USD0.001
Nasdaq2024/12/0622:0092.13 USD413.4452,530
Munich2024/12/0608:0588.22 EUR0.002
Hanover2024/12/0617:2587.64 EUR0.004
Hamburg2024/12/0617:2587.64 EUR0.004
Frankfurt2024/12/0615:1188.27 EUR0.043
Euronext Milan MTF Trading After Hours2024/11/2719:4687.83 EUR0.001
Euronext Milan MTF Global Equity Market2024/12/0617:4487.59 EUR0.013
Duesseldorf2024/12/0619:3087.43 EUR0.007
Berlin2024/12/0608:0888.18 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1964&ID_TYPE_IMAGE_LOGO=2

Contact Details

GILEAD SCIENCES INC.
- -
333 Lakeside Drive - 94404 Foster City
Telefon: +1-650-574-3000
Fax: +1-650-522-5853
E-mail: -

PDF Downloads

Company report: GILEAD SCIENCES INC.PDF Download

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Members of Management Board

Jacqueline BartonMember of Board of Directors
Jeffrey BluestoneMember of Board of Directors
Sandra HorningMember of Board of Directors
Ted LoveMember of Board of Directors
Anthony WeltersMember of Board of Directors
Harish M. ManwaniMember of Board of Directors
Javier RodriguezMember of Board of Directors
Kelly KramerMember of Board of Directors
Daniel O'DayChairman of Managing Board
Andrew DickinsonMember of Executive Committee
Deborah H. TelmanMember of Executive Committee
Flavius MartinMember of Executive Committee
Johanna MercierMember of Executive Committee
Jyoti MehraMember of Executive Committee
MD, PhD Merdad ParseyMember of Executive Committee
Stacey MaMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer